Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

673
The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic...
673
Diversity of Protists I01:15

Diversity of Protists I

1.6K
Excavata is a diverse group of protists that includes both chemoorganotrophic and phototrophic species, with some thriving in anaerobic environments. Among the key groups within Excavata are diplomonads and parabasalids, which are flagellated protists that lack mitochondria and chloroplasts. These microorganisms typically inhabit anoxic environments, such as the intestines of animals, where they exist either symbiotically or as parasites, relying on fermentation for energy production. Some...
1.6K
Bacterial Phylum Proteobacteria01:26

Bacterial Phylum Proteobacteria

1.1K
Proteobacteria, one of the largest and most diverse bacterial phyla, encompasses a wide range of Gram-negative bacteria distinguished by their outer membrane composed of lipopolysaccharides. These microorganisms exhibit various metabolic capabilities, including phototrophy, chemolithotrophy, and heterotrophy, and thrive in diverse environments from soil to aquatic systems and host-associated niches. The phylum is divided into six classes: Alphaproteobacteria, Betaproteobacteria,...
1.1K
Stringent Response in E. coli01:23

Stringent Response in E. coli

420
Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
420
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

508
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
508
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

1.4K
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.4K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Expanding cholera serosurveillance to vaccinated populations.

medRxiv : the preprint server for health sciences·2025
Same author

Immunogenicity and safety of an Escherichia coli-produced bivalent human papillomavirus vaccine (Cecolin) in girls aged 9-14 years in Ghana and Bangladesh: a randomised, controlled, open-label, non-inferiority, phase 3 trial.

The Lancet. Infectious diseases·2025
Same author

Evolution of long COVID over two years in hospitalised and non-hospitalised survivors in Bangladesh: a longitudinal cohort study.

Journal of global health·2025
Same author

Physicians' Perspectives Regarding Informal Health Practitioners in Bangladesh.

The American journal of tropical medicine and hygiene·2025
Same author

Tebipenem pivoxil as an alternative to ceftriaxone for clinically non-responding children with shigellosis: a randomised non-inferiority trial protocol.

BMJ open·2025
Same author

Efficacy, Safety, and Immunogenicity of Biosimilar Adalimumab Advixa® Compared With Reference Product Humira® in Patients With Rheumatoid Arthritis in Bangladesh.

Cureus·2025

関連する実験動画

Updated: Feb 28, 2026

Quantifying Vibrio cholerae Colonization and Diarrhea in the Adult Zebrafish Model
08:03

Quantifying Vibrio cholerae Colonization and Diarrhea in the Adult Zebrafish Model

Published on: July 12, 2018

9.0K

コレラ

John D Clemens1, G Balakrish Nair2, Tahmeed Ahmed3

  • 1International Centre for Diarrhoeal Disease Research, Bangladesh, Centre for Health and Population Research, Dhaka, Bangladesh; UCLA Fielding School of Public Health, Los Angeles, CA, USA; Korea University School of Medicine, Seoul, Korea.

Lancet (London, England)
|March 18, 2017
PubMed
まとめ

ひどい下痢性疾患であるコレラは 効果的な補水療法にも関わらず 毎年10万人を殺しています 新しい口服ワクチンは 腸内免疫力を高め この持続的な世界的な健康上の脅威から 守っています

さらに関連する動画

Laboratory Techniques Used to Maintain and Differentiate Biotypes of Vibrio cholerae Clinical and Environmental Isolates
07:58

Laboratory Techniques Used to Maintain and Differentiate Biotypes of Vibrio cholerae Clinical and Environmental Isolates

Published on: May 30, 2017

11.6K
Determination of Tolerable Fatty Acids and Cholera Toxin Concentrations Using Human Intestinal Epithelial Cells and BALB/c Mouse Macrophages
09:39

Determination of Tolerable Fatty Acids and Cholera Toxin Concentrations Using Human Intestinal Epithelial Cells and BALB/c Mouse Macrophages

Published on: May 30, 2013

10.5K

関連する実験動画

Last Updated: Feb 28, 2026

Quantifying Vibrio cholerae Colonization and Diarrhea in the Adult Zebrafish Model
08:03

Quantifying Vibrio cholerae Colonization and Diarrhea in the Adult Zebrafish Model

Published on: July 12, 2018

9.0K
Laboratory Techniques Used to Maintain and Differentiate Biotypes of Vibrio cholerae Clinical and Environmental Isolates
07:58

Laboratory Techniques Used to Maintain and Differentiate Biotypes of Vibrio cholerae Clinical and Environmental Isolates

Published on: May 30, 2017

11.6K
Determination of Tolerable Fatty Acids and Cholera Toxin Concentrations Using Human Intestinal Epithelial Cells and BALB/c Mouse Macrophages
09:39

Determination of Tolerable Fatty Acids and Cholera Toxin Concentrations Using Human Intestinal Epithelial Cells and BALB/c Mouse Macrophages

Published on: May 30, 2013

10.5K

科学分野:

  • 感染症
  • 公衆衛生
  • ワクチン学

背景:

  • コレラは,Vibrio cholerae O1またはO139血清群によって引き起こされる急性,水性下痢性疾患である.
  • 歴史的に見て コレラはガンジス・デルタや インドネシアから発生した 複数の世界的なパンデミックを引き起こしました
  • リヒダレーション 療法 の 進歩 に よっ て 死亡 率 が 1% 以下 に 減少 し て いる に も かかわら ず,コレラ は 今 も 毎年 推定 100,000 人 の 死 を 引き起こし て い ます.その 大半 は 発展 し て いる 国 で ある.

研究 の 目的:

  • 流行病学,歴史的影響,現在の公衆衛生上の重要性を含むコレラの概要を提供すること.
  • コレラ症例管理と効果的なワクチンの開発における進歩を強調する.
  • コレラ予防ワクチンの開発における局所腸内免疫の役割について議論する.

主な方法:

  • コレラ・パンデミックと死亡率に関する過去のデータのレビュー
  • コレラの発生率と死亡率に関する現在の疫学データの分析
  • コレラの病原性と免疫反応に関する科学的理解の要約
  • コレラワクチンの開発と備蓄の概要

主要な成果:

  • 経口および静脈注射による再水分化により,コレラによる死亡率は1%未満に減少しました.
  • コレラによる死亡者は年間10万人に達し,その多くは開発途上国の流行地域です.
  • 腸内免疫の理解に基づいた安全で効果的な経口コレラワクチンが開発され,世界中で蓄積されています.

結論:

  • コレラは,特に資源が少ない環境で,世界的な健康上の大きな課題です.
  • 経口補水療法は コレラの生存率を劇的に改善しました
  • 口服によるコレラワクチンの開発は,流行性コレラと流行性コレラの両方を制御する上で大きな進歩を意味します.